Clinical trial

Effects of Atazanavir Treatment on Type 2 Diabetes Mellitus Related Endothelial Dysfunction

NCT00696722

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention placebo + atazanavir Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention atazanavir + placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Effects of Atazanavir Treatment on Type 2 Diabetes Mellitus Related Endothelial Dysfunction

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-06-01

PhasePHASE2

Conditions

Type 2 Diabetes Mellitus Related Endothelial Dysfunctionunresolved

Interventions

placebo + atazanavirDRUG

atazanavir + placeboDRUG

Sponsors & collaborators

Radboud University Medical Centerlead sponsor

Dutch Diabetes Research Foundationcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00696722 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.